在COVID-19 mRNA疫苗接种后出现呼吸衰竭的间歇性肺病
Soichi Maruyama1, Taro Takahashi1, Daisuke Kobayashi2
1Department of Respiratory Medicine, Nerima Hikarigaoka Hospital, Tokyo, JPN.
Cureus
|May 20, 2024
概括
在她第五次COVID-19mRNA疫苗接种后,一位七十多岁的老人出现了呼吸短促,成像显示肺部异常. 尽管接受了治疗,但她患上了持续的肺纤维化,这表明了与疫苗有关的复杂肺损伤.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- COVID-19 mRNA疫苗与各种不良事件有关.
- 间歇性肺病 (ILD) 是一种罕见但严重的潜在并发症.
- 早期识别和管理与疫苗相关的ILD至关重要.
相关概念视频
Acute Respiratory Failure-II
210
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
210
Acute Respiratory Failure-I
198
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
198
Acute Respiratory Failure-III
178
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
178
Acute Respiratory Failure-V
132
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
132
Pneumonia II: Pathophysiology
258
The pathophysiology of pneumonia involves the following steps:
258
Pneumonia III: Complications and Assessment
202
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
202


